IMC Chicago’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
16,000
-11,500
-42% -$1.15M ﹤0.01% 2873
2025
Q4
$2.81M Sell
27,500
-6,300
-19% -$564K ﹤0.01% 2161
2025
Q3
$2.11M Buy
33,800
+22,800
+207% +$1.24M ﹤0.01% 2178
2025
Q2
$572K Buy
+11,000
New +$491K ﹤0.01% 2785

Other funds holding GH

IMC Chicago's GH Position: Q1 2026 in Review

IMC Chicago reduced its Guardant Health (GH) stake by 15% in Q1 2026, selling an estimated $205K and leaving 11,387 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

IMC Chicago first reported a position in GH in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.37M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • IMC Chicago held 11,387 shares of Guardant Health worth $1.05M as of Q1 2026.
  • IMC Chicago sold 2,041 Guardant Health shares in Q1 2026, an estimated $205K.
  • Guardant Health made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3234 holding.
  • IMC Chicago first reported a position in Guardant Health in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Guardant Health position peaked at $1.37M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.